Showing results (21-30 of 38) with videos related to
Sort By:
Pageof 4
British Poultry Science|March 25, 1998
Effects of AvGard treatment on the microbiological flora of poultry carcasesG Salvat, P Coppen, J C Allo, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 15, 2011
The evolution of the OATP hepatic uptake transport protein family in DMPK sciences: from obscure liver transporters to key determinants of hepatobiliary clearanceKatherine S Fenner, Hannah M Jones, Mohammed Ullah, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 17, 2001
Absorption, distribution, metabolism, and excretion considerations in selection of orally active indole-containing endothelin antagonistD K Walker, K N Dack, R P Dickinson, et al.Clinical Pharmacology and Therapeutics|November 7, 2008
Drug-drug interactions mediated through P-glycoprotein: clinical relevance and in vitro-in vivo correlation using digoxin as a probe drugK S Fenner, M D Troutman, S Kempshall, et al.Journal of Pharmaceutical Sciences|April 18, 2009
N-(3,4-dimethoxyphenethyl)-4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2[1H]-yl)-6,7-dimethoxyquinazolin-2-amine (CP-100,356) as a "chemical knock-out equivalent" to assess the impact of efflux transporters on oral drug absorption in the ratAmit S Kalgutkar, Kosea S Frederick, Jonathan Chupka, et al.Research in Veterinary Science|February 23, 2010
Analysis of 16S rDNA sequences from pathogenic Leptospira serovars and use of single nucleotide polymorphisms for rapid speciation by D-HPLCJ S Fenner, M F Anjum, L P Randall, et al.Current Drug Metabolism|December 30, 2010
Targeting intestinal transporters for optimizing oral drug absorptionManthena V Varma, Catherine M Ambler, Mohammad Ullah, et al.British Journal of Clinical Pharmacology|March 12, 2011
A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladderErnesto Callegari, Bimal Malhotra, Peter J Bungay, et al.Molecular Pharmaceutics|December 23, 2009
Refining the in vitro and in vivo critical parameters for P-glycoprotein, [I]/IC50 and [I2]/IC50, that allow for the exclusion of drug candidates from clinical digoxin interaction studiesJack A Cook, Bo Feng, Katherine S Fenner, et al.Molecular Pharmacology|May 4, 2018
Molecular Mechanisms for Species Differences in Organic Anion Transporter 1, OAT1: Implications for Renal Drug ToxicityLing Zou, Adrian Stecula, Anshul Gupta, et al.Pageof 4